Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR

Journal of Clinical Microbiology

Volumn 44, Issue 9, 2006, Pages 3292-3298

  Van Doorn, Leen Jan ^a   Molijn, Anco ^a   Kleter, Bernhard ^a   Quint, Wim ^a   Colau, Brigitte ^b  

^a DDL DIAGNOSTIC LABORATORY   (Netherlands)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE;

ADOLESCENT; ADULT; ALGORITHM; ARTICLE; BROAD SPECTRUM POLYMERASE CHAIN REACTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA DETERMINATION; ENZYME IMMUNOASSAY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; LABORATORY DIAGNOSIS; MIXED INFECTION; NONHUMAN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TYPE SPECIFIC POLYMERASE CHAIN REACTION; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS INFECTION;

ADOLESCENT; ADULT; ALGORITHMS; CERVIX UTERI; DNA PROBES, HPV; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; TREATMENT OUTCOME; VIRAL VACCINES;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 33748784911     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00539-06     Document Type: Article

References (37)

1. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
2. Baay, M. F., W. G. V. Quint, J. Koudstaal, H. Hollema, J. M. Duk, M. P. Burger, E. Stolz, and P. Herbrink. 1996. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J. Clin. Microbiol. 34:745-747.
3. Bozzetti, M., B. Nonnenmacher, I. Mielzinska, L. Villa, A. Lorincz, V. Breitenbach, and J. Prolla. 2000. Comparison between Hybrid Capture II and polymerase chain reaction results among women at low risk for cervical cancer. Ann. Epidemiol. 10:466.
4. Chan, S. Y., H. Delius, A. L. Halpern, and H. U. Bernard. 1995. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J. Virol. 69:3074-3083.
5. Cogliano, V., R. Baan, K. Straif, Y. Grosse, B. Secretan, and G. F. El. 2005. Carcinogenicity of human papillomaviruses. Lancet Oncol. 6:204.
6. Coutlee, F., P. Gravitt, J. Kornegay, C. Hankins, H. Richardson, N. Lapointe, H. Voyer, and E. Franco. 2002. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J. Clin. Microbiol. 40:902-907.
7. Cox, J. T., A. T. Lorincz, M. H. Schiffman, M. E. Sherman, A. Cullen, and R. J. Kurman. 1995. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am. J. Obstet. Gynecol. 172: 946-954.
8. Cuzick, J., P. Sasieni, P. Davies, J. Adams, C. Normand, A. Frater, M. van Ballegooijen, and E. van den Akker. 1999. A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol. Assess. 3:1-201.
9. Dalstein, V., D. Riethmuller, J. L. Pretet, C. K. Le Bail, J. L. Sautiere, J. P. Carbillet, B. Kantelip, J. P. Schaal, and C. Mougin. 2003. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int. J. Cancer 106:396-403.
10. de Roda Husman, A. M., J. M. Walboomers, A. J. van den Brule, C. J. Meijer, and P. J. Snijders. 1995. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Virol. 76:1057-1062.
11. Gravitt, P. E., J. V. Lacey, L. A. Brinton, W. A. Barnes, J. R. Kornegay, M. D. Greenberg, S. M. Greene, O. C. Hadjimichael, L. McGowan, R. Mortel, P. E. Schwartz R. Zaino, and A. Hildesheim. 2001. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol. Biomarkers Prev. 10:95-100.
12. Gravitt, P. E., and M. M. Manos. 1992. Polymerase chain reaction-based methods for the detection of human papillomavirus DNA. IARC Sci. Publ. 119:121-133.
13. Gravitt, P. E., C. L. Peyton, T. Q. Alessi, C. M. Wheeler, F. Coutlée, A. Hildesheim, M. Schiffman, D. R. Scott, and R. J. Apple. 2000. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38:357-361.
14. Gravitt, P. E., C. L. Peyton, R. J. Apple, and C. M. Wheeler. 1998. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J. Clin. Microbiol. 36:3020-3027.
15. Harper, D. M., E. L. Franco, C. Wheeler, D. G. Ferris, D. Jenkins, A. Schuind, T. Zahaf, B. Innis, P. Naud, N. S. De Carvalho, C. M. Roteli-Martins, J. Teixeira, M. M. Blatter, A. P. Korn, W. Quint, and G. Dubin. 2004. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364:1757-1765.
16. Heinmoller, E., B. Renke, K. Beyser, W. Dietmaier, C. Langner, and J. Ruschoff. 2001. Piffalls in diagnostic molecular pathology-significance of sampling error. Virchows Arch. 439:504-511.
17. Hildesheim, A., M. H. Schiffman, P. E. Gravitt, A. G. Glass, C. E. Greer, T. Zhang, D. R. Scott, B. B. Rush, P. Lawler, M. E. Sherman, R. J. Kurman, and M. M. Manos. 1994. Persistence of type-specific human papillomavirus infection among cytologically normal women. J. Infect. Dis. 169:235-240.
18. Jacobs, M. V., P. J. Snijders, A. J. van den Brule, T. J. Helmerhorst, C. J. Meyer, and J. M. Walboomers. 1997. A general primer GP5+/GP6+-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J. Clin. Microbiol. 35:791-795.
19. Kleter, B., L. J. van Doorn, L. Schrauwen, A. Molijn, S. Sastrowijoto, J. ter Schegget, J. Lindeman, B. ter Harmsel, and W. G. V. Quint. 1999. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37:2508-2517.
20. Kleter, B., L. J. van Doorn, J. ter Schegget, L. Schrauwen, C. van Krimpen, M. P. Burger, B. ter Harmsel, and W. G. V. Quint. 1998. A novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am. J. Pathol. 153:1731-1739.
21. Koutsky, L. A., K. A. Ault, C. M. Wheeler, D. R. Brown, E. Barr, F. B. Alvarez, L. M. Chiacchierini, and K. U. Jansen. 2002. A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med. 347:1645-1651.
22. Levi, J. E., B. Kleter, W. G. Quint, M. C. Fink, C. L. Canto, R. Matsubara, I. Linhares, A. Segurado, B. Vandenborght, J. E. Neto, and L. J. van Doorn. 2002. High prevalence of human papillomavirus infections and high frequency of multiple genotypes in HIV-infected women in Brazil. J. Clin. Microbiol. 40:3341-3345.
23. Munoz, N., F. X. Bosch, S. De Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
24. Parkin, D. M., F. Bray, J. Ferlay, and P. Pisani. 2005. Global cancer statistics, 2002. CA Cancer J. Clinicians 55:74-108.
25. Perrons, C., R. Jelley, B. Kleter, W. Quint, and N. Brink. 2005. Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA. J. Clin. Virol. 32:278-285.
26. Qu, W., G. Jiang, Y. Cruz, C. J. Chang, G. Y. Ho, R. S. Klein, and R. D. Burk. 1997. PCR detection of human papillomavirus: comparison between MY09/ MY11 and GP5+/GP6+ primer systems. J. Clin. Microbiol. 35:1304-1310.
27. Saiki, R. K., D. H. Gelfand, S. Stoffel, S. J. Scharf, R. Higuchi, G. T. Horn, K. B. Mullis, and H. A. Erlich. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491.
28. Schlecht, N. F., A. Trevisan, E. Duarte-Franco, T. E. Rohan, A. Ferenczy, L. L. Villa, and E. L. Franco. 2003. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int. J. Cancer 103:519-524.
29. Snijders, P. J., A. J. van den Brule, and C. J. Meijer. 2003. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J. Pathol. 201:1-6.
30. van den Brule, A. J., R. Pol, N. Fransen-Daalmeijer, L. M. Schouls, C. J. Meijer, and P. J. Snijders. 2002. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J. Clin. Microbiol. 40:779-787.
31. van Doorn, L. J., B. Kleter, and W. G. Quint. 2001. Molecular detection and genotyping of human papillomavirus. Expert Rev. Mol. Diagn. 1:394-402.
32. 10 line probe assay in liquid cytology cervical specimens. J. Clin. Microbiol. 40:979-983.
33. Villa, L. L., R. L. Costa, C. A. Petta, R. P. Andrade, K. A. Ault, A. R. Giuliano, C. M. Wheeler, L. A. Koutsky, C. Malm, M. Lehtinen, F. E. Skjeldestad, S. E. Olsson, M. Steinwall, D. R. Brown, R. J. Kurman, B. M. Ronnett, M. H. Stoler, A. Ferenczy, D. M. Harper, G. M. Tamms, J. Yu, L. Lupinacci, R. Railkar, F. J. Taddeo, K. U. Jansen, M. T. Esser, H. L. Sings, A. J. Saah, and E. Barr. 2005. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 6:271-278.
34. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
35. Woodman, C. B., S. Collins, H. Winter, A. Bailey, J. Ellis, P. Prior, M. Yates, T. P. Rollason, and L. S. Young. 2001. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357:1831-1836.
36. Ylitalo, N., P. Sorensen, A. M. Josefsson, P. K. Magnusson, P. K. Andersen, J. Ponten, H. O. Adami, U. B. Gyllensten, and M. Melbye. 2000. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 355:2194-2198.
37. zur Hausen, H., and O. De Barahona. 1994. Human papillomaviruses. Annu. Rev. Microbiol. 48:427-447.